As of October 2024, Hikma Pharmaceuticals has a market cap of $5.59B. This makes Hikma Pharmaceuticals the world's 2551th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $5.80B | 11.07% |
2023 | $5.22B | 15.27% |
2022 | $4.53B | -30.06% |
2021 | $6.48B | -11.87% |
2020 | $7.35B | 26.47% |
2019 | $5.81B | 16.03% |
2018 | $5.01B | 51.32% |
2017 | $3.31B | -40.10% |
2016 | $5.52B | -17.73% |
2015 | $6.71B | 16.27% |
2014 | $5.78B | 64.78% |
2013 | $3.50B | 57.82% |
2012 | $2.22B | 22.74% |
2011 | $1.81B | -23.60% |
2010 | $2.37B | 59.12% |
2009 | $1.49B | 45.71% |
2008 | $1.02B | -26.04% |
2007 | $1.38B | 29.57% |
2006 | $1.07B | -9.76% |
2005 | $1.18B | - |